References
- Couser WG, Salant DJ. Immunopathogenesis of glomerular capillary wall injury in nephrotic states. In: Brenner BM, Stein JH, eds. Nephrotic Syndrome. New York: Longman (Churchill Livingstone), 1982: 47–83 (Contemporary issues in nephrology series, vol 9)
- Bender WL, Whelton A, Beschorner WE, et al. interstitial nephritis. Proteinuria, and renal failure caused by non-steroidal anti-inflammatory drugs: immunologic characterization of the inflammatory infiltrate. Am J Med 1984: 76(6): 1006–12
- Brenner BM. Hostetter TH, Humes HD. Molecular basis of proteinuria of glomerular origin. N Engl J Med 1978: 298(15): 826–33
- McEnery PT, Strife CF. Nephrotic Syndrome in childhood: management and treatment in patients with minimal change disease. mesangial proliferation. or focal glomerulosclerosis. Pediatr Clin North Am 1982: 29(4): 875–94
- Glassock RJ, Cohen AH, Bennett CM, et al. Primary glomerular diseases. In: Brenner BM. Rector FC Jr, eds. The kidney. Philadelphia: WB Saunders, 1981: 1351–492
- Mitas JA, Llach F. Investigation of the nephrotic patient In: Cameron JS, Glassock RJ, eds. Nephrotic Syndrome. New York: Marcel Dekker (in press)
- Llach F. Descoeudres C, Massry SG. Heroin associated nephropathy: clinical and histological studies in 19 patients. Clin Nephrol 1979: 11(1): 7–12
- Young DS. Pestaner LC, Gibberman V. Effects of drugs on clinical laboratory tests. Clin Chem 1975: 21(5): ID–432D
- Rowe JW. Andres R. Tobin JD, et al. Age-adjusted Standards for Creatinine clearance. (Letter) Ann Intern Med 1976: 84(5): 567–9
- Ginsberg JM, Chang BS. Matarese RA. et al. Use of Single voided urine samples to estimate quantitative proteinuria. N Engl J Med 1983: 309(25): 1543–6
- Mitas JA. Exogenous protein as the etiology of nephrotic range proteinuria. Am J Med (in press)
- Zech P, Colon S, Pointet P, et al. The nephrotic Syndrome in adults aged over 60: etiology, evolution, and treatment of 76 cases. Clin Nephrol 1982: 17(5): 232–6
- Kassirer JP. Is renal biopsy necessary for optimal management of the idiopathic nephrotic Syndrome? Kidney Int 1983: 24(4): 561–75
- Paone DB. Meyer LR. The effect of biopsy on therapy in renal disease. Arch Intern Med 1981: 141(8): 1039–41
- Mallick NP, Dosa S, Acheson EJ, et al. Detection, significance and treatment of paraprotein in patients presenting with “idiopathic” proteinuria without myeloma. Q J Med 1978: 47(186): 145–75
- Carette S, Klippel JH. Decker JL, et al. Controlled studies of oral immunosuppressive drugs in lupus nephritis: a long-term follow-up. Ann Intern Med 1983: 99(1): 1–8
- Robinson WL, Mitas JA, Haerr RW, et al. Remission and exacerbation of tumor-related nephrotic Syndrome with treatment of the neoplasm. Cancer 1984: 54(6): 1082–4
- Zimmerman SW, Moorthy AV, Dreher WH, et al. Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephrits. Am J Med 1983: 75(6): 920–7
- Donadio JV Jr, Anderson CF, Mitchell JC 3d. et al. Membranoproliferative glomerulonephritis: a prospective clinical trial of platelet inhibitor therapy. N Engl J Med 1984: 310(22): 1421–6
- Ponticelli C, Zucchelli P, Imbasclati E, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 1964: 310(15): 946–50
- Warren SE, Mitas JA 2d, Golbus SM, et al. Recovery from rapidly progressive glomerulonephritis: Improvement after plasmapheresis and immunosuppression. Arch Intern Med 1981: 141(2): 175–80